Young Children Found to Have Greater Potential to Spread COVID-19
Children aged <5 years were found to have significantly greater levels of SARS-CoV-2 viral nucleic acid compared with older children and adults.
Respiratory Diseases/Disorders
High Prevalence of Americans Have Conditions Linked to Severe COVID-19
Dr. Razzaghi and colleagues estimated the county-level prevalence of selected conditions associated with severe COVID-19.
Strategic Guidelines for Managing Community-Acquired Pneumonia in Immunocompromised Populations Developed
In immunocompromised adults, community-acquired pneumonia should be treated by a multidisciplinary team of physicians.
COVID-19 Patients With Elevated CRP May Benefit From Steroid Therapy
The observational study, which was led by the Albert Einstein College of Medicine and Montefiore Health System, aimed to assess the effect of glucocorticoid therapy on mortality and the need for mechanical ventilation in hospitalized patients with COVID-19.
Comparison of Systematic vs Test-Guided Treatment for TB in Adults With HIV
A team of investigators conducted a randomized trial comparing test-guided management of tuberculosis with systematic empirical treatment for adults with HIV infection.
Asthma Management During COVID-19: Canadian Thoracic Society Position Statement
The Canadian Thoracic Society’s Position Statement on the Optimization of Asthma Management during the COVID-19 pandemic had several key insights.
Impact of COVID-19 on Correctional and Detention Facilities
The CDC advises that administrators of correctional and detention facilities implement measures to prevent the spread of COVID-19.
Clinical Program Investigating Dual Antibody Cocktail for COVID-19 Begins
Regeneron has initiated its first human clinical trials evaluating an investigational antiviral antibody cocktail, REGN-COV2, for the prevention and treatment of coronavirus disease 2019 (COVID-19).
Early Data Show Potential Benefit of Acalabrutinib in Severe COVID-19
Acalabrutinib, a Bruton tyrosine kinase (BTK) inhibitor, appears to reduce respiratory distress as well as the hyperinflammatory immune response associated with coronavirus disease 2019.
Remdesivir Improves Time To Recovery for Patients Hospitalized With COVID-19
Treatment with remdesivir was associated with a shorter time to recovery in patients hospitalized with coronavirus disease 2019 (COVID-19), according to peer-reviewed data published in the New England Journal of Medicine.
-
Loading...
-
Loading...
Next post in Infectious Diseases Information Center
